Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Other Non-Current Assets of $12.0 million in Q4 2025, little changed quarter-over-quarter from $12.0 million in Q4 2024, and little changed on a YoY basis from $12.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $12.0 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (changed 0.0% YoY), while the FY2025 annual figure was $12.0 million, changed 0.0% from the prior year.
- Other Non-Current Assets was $12.0 million for Q4 2025 at Curaleaf Holdings, roughly flat from $12.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $46.8 million in Q2 2023 to a low of -$34.3 million in Q3 2022.
- Historically, Other Non-Current Assets has averaged $9.9 million across 5 years, with a median of $8.6 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets surged 1958.42% in 2021, then tumbled 249.85% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $6.7 million in 2021, then jumped by 132.29% to $15.5 million in 2022, then tumbled by 44.37% to $8.6 million in 2023, then surged by 39.53% to $12.0 million in 2024, then changed by 0.0% to $12.0 million in 2025.
- The last three Other Non-Current Assets figures came in at $12.0 million (Q4 2025), $12.0 million (Q4 2024), and $8.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 8.16 Mn |
| Jun 30, 2024 | 9.11 Mn |
| Dec 31, 2023 | 8.60 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 46.79 Mn |
| Dec 31, 2022 | 15.46 Mn |
| Sep 30, 2022 | -34.28 Mn |
| Jun 30, 2022 | 3.74 Mn |
| Mar 31, 2022 | 3.58 Mn |
| Dec 31, 2021 | 6.66 Mn |
| Sep 30, 2021 | 22.88 Mn |
| Jun 30, 2021 | 24.71 Mn |
| Mar 31, 2021 | 5.99 Mn |
| Dec 31, 2020 | 35.14 Mn |
| Sep 30, 2020 | 5.54 Mn |
| Jun 30, 2020 | -1.44 Mn |
| Mar 31, 2020 | 291,000.00 |
| Dec 31, 2019 | 8.83 Mn |